Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cancer Cell

• Publication date

  2016-02-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ccell.2016.01.006PMID 26859455
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of MK2 suppresses IL‐1β, IL‐6, and TNF‐α‐dependent colorectal cancer growth

  2018cited by this paper
• Faculty Opinions recommendation of Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha.

  2015cited by this paper
• RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL

  2015cited by this paper
• Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML

  2014influential reference
• IAP family of cell death and signaling regulators.

  2014influential reference
• PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK 1-and RIPK 3-dependent manner

  2014influential reference
• Birinapant, a smac-mimetic with improved tolerability for the treatment of solid tumors and hematological malignancies.

  2014influential reference
• Mitogen-Activated Protein Kinase–Activated Protein Kinase 2 in Neuroinflammation, Heat Shock Protein 27 Phosphorylation, and Cell Cycle: Role and Targeting

  2014cited by this paper
• Synergistic targeting of AML stem/progenitor cells with IAP antagonist birinapant and demethylating agents.

  2014cited by this paper
• LY2228820 Dimesylate, a Selective Inhibitor of p38 Mitogen-activated Protein Kinase, Reduces Angiogenic Endothelial Cord Formation in Vitro and in Vivo*

  2013cited by this paper
• Kinase drug discovery--what's next in the field?

  2013cited by this paper
• Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation.

  2013influential reference
• Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial.

  2013cited by this paper
• A public-private partnership to unlock the untargeted kinome.

  2013cited by this paper
• The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism.

  2013cited by this paper
• Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation.

  2012cited by this paper
• Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia

  2012cited by this paper
• New induction and postinduction strategies in acute myeloid leukemia

  2012cited by this paper
• A novel role for RIP1 kinase in mediating TNFα production

  2012cited by this paper
• Targeting IAP proteins for therapeutic intervention in cancer

  2012cited by this paper
• Discovery of potent and selective covalent inhibitors of JNK.

  2012cited by this paper
• Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase.

  2012cited by this paper
• Clinical and proteomic characterization of acute myeloid leukemia with mutated RAS

  2012cited by this paper
• cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms

  2011cited by this paper
• Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity

  2011cited by this paper
• S-Nitrosylation at the interface of autophagy and disease.

  2011cited by this paper
• The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs.

  2011cited by this paper
• Deregulated apoptosis signaling in core-binding factor leukemia differentiates clinically relevant, molecular marker-independent subgroups

  2011cited by this paper
• A Benzothiophene Inhibitor of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 Inhibits Tumor Necrosis Factor α Production and Has Oral Anti-Inflammatory Efficacy in Acute and Chronic Models of Inflammation

  2010cited by this paper
• Anthracycline dose intensification in acute myeloid leukemia.

  2009cited by this paper
• Mouse models of human AML accurately predict chemotherapy response.

  2009cited by this paper
• Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

  2009cited by this paper
• Inhibition of p38: has the fat lady sung?

  2009cited by this paper
• Identification of the murine firefly luciferase-specific CD8 T-cell epitopes

  2009cited by this paper
• Induction of hepatitis by JNK-mediated expression of TNF-alpha.

  2009cited by this paper
• Targeting protein kinases for the development of anti-inflammatory drugs.

  2009cited by this paper
• Targeting innate immunity protein kinase signalling in inflammation

  2009influential reference
• Anthracycline dose intensification in acute myeloid leukemia.

  2009cited by this paper
• Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha.

  2009cited by this paper
• The Discovery of the Benzhydroxamate MEK Inhibitors CI‐1040 and PD 0325901.

  2009influential reference
• The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia.

  2008cited by this paper
• Activation of noncanonical NF-κB requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2, TRAF3 and the kinase NIK

  2008cited by this paper
• The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901.

  2008cited by this paper
• Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling

  2008influential reference
• cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination.

  2008cited by this paper
• IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis.

  2007influential reference
• Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis.

  2007cited by this paper
• A Smac mimetic rescue screen reveals roles for inhibitor of apoptosis proteins in tumor necrosis factor-alpha signaling.

  2007cited by this paper
• IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.

  2007influential reference
• The Mitogen-Activated Protein Kinase (MAPK)-Activated Protein Kinases MK2 and MK3 Cooperate in Stimulation of Tumor Necrosis Factor Biosynthesis and Stabilization of p38 MAPK

  2006cited by this paper
• Toll-like receptor signalling

  2004cited by this paper
• Feedback control of the protein kinase TAK1 by SAPK2a/p38α

  2003cited by this paper
• NF-κB Signals Induce the Expression of c-FLIP

  2001cited by this paper
• TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway.

  2000influential reference
• TNF-a Induction by LPS Is Regulated Posttranscriptionally via a Tpl2/ERK-Dependent Pathway

  2000cited by this paper
• Kotlyarov, A. et al. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat. Cell Biol. 1, 94-97

  1999cited by this paper
• MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis.

  1999cited by this paper
• IAPs block apoptotic events induced by caspase‐8 and cytochrome c by direct inhibition of distinct caspases

  1998cited by this paper
• X-linked IAP is a direct inhibitor of cell-death proteases

  1997cited by this paper
• Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages

  1990influential reference

• Targeting p38α in cancer: challenges, opportunities, and emerging strategies.

  2026cites this paper
• Overexpression and oncogenic role of RIPK3 in acute myeloid leukemia associated with specific subtypes and treatment outcome

  2025cites this paper
• Mitochondrial P-JNK target, SAB (SH3BP5), in regulation of cell death

  2024cites this paper
• Anthrax lethal toxin and tumor necrosis factor-α synergize on intestinal epithelia to induce mouse death

  2023cites this paper
• 5-Iodotubercidin sensitizes cells to RIPK1-dependent necroptosis by interfering with NFκB signaling

  2023cites this paper
• Bacillus anthracis induces NLRP3 inflammasome activation and caspase-8–mediated apoptosis of macrophages to promote lethal anthrax

  2022cites this paper
• MAPK-Activated Protein Kinases: Servant or Partner?

  2022cites this paper
• X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL

  2022cites this paper
• p38MAPK guards the integrity of endosomal compartments through regulating necrotic death

  2022cites this paper
• Tankyrase-mediated ADP-ribosylation is a regulator of TNF-induced death

  2022cites this paper
• The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL

  2022cites this paper
• Combining Oncolytic Viruses and Small Molecule Therapeutics: Mutual Benefits

  2021cites this paper
• The p38 MAPK Components and Modulators as Biomarkers and Molecular Targets in Cancer

  2021cites this paper
• Characterization and Cytotoxicity of Pseudomonas Mediated Rhamnolipids Against Breast Cancer MDA-MB-231 Cell Line

  2021cites this paper
• RIPK3 signaling and its role in the pathogenesis of cancers

  2021cites this paper
• Promyelocytic leukemia protein targets MK2 to promote cytotoxicity

  2021cites this paper
• NF-κB and Pancreatic Cancer; Chapter and Verse

  2021cites this paper
• Protein degradation technology: a strategic paradigm shift in drug discovery

  2021cites this paper
• Probing Synergistic Targets by Natural Compounds for Hepatocellular Carcinoma

  2021cites this paper
• Diversity and versatility of p38 kinase signalling in health and disease

  2021cites this paper
• Current status and future prospects of p38α/MAPK14 kinase and its inhibitors.

  2021cites this paper
• A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cells

  2020cites this paper
• IAP inhibitor, Embelin increases VCAM-1 levels on the endothelium, producing lymphocytic infiltration and antitumor immunity

  2020cites this paper
• Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML models.

  2020cites this paper
• Activity of Birinapant, a SMAC Mimetic Compound, Alone or in Combination in NSCLCs With Different Mutations

  2020cites this paper
• Nuclear P38: Roles in Physiological and Pathological Processes and Regulation of Nuclear Translocation

  2020cites this paper
• Combinatorial Treatment of Birinapant and Zosuquidar Enhances Effective Control of HBV Replication In Vivo

  2020cites this paper
• Iron Oxide Nanoparticles as Autophagy Intervention Agents Suppress Hepatoma Growth by Enhancing Tumoricidal Autophagy

  2020cites this paper
• Identification of MYC as an antinecroptotic protein that stifles RIPK1–RIPK3 complex formation

  2020cites this paper
• An overview of mammalian p38 mitogen-activated protein

  2020cites this paper
• Inhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance.

  2020cites this paper
• RIPK1‐mediated immunogenic cell death promotes anti‐tumour immunity against soft‐tissue sarcoma

  2020cites this paper
• Targeting triple-negative breast cancers with the Smac-mimetic birinapant

  2020cites this paper
• Targeting Apoptosis in Acute Myeloid Leukemia: Current Status and Future Directions of BCL-2 Inhibition with Venetoclax and Beyond

  2020cites this paper
• MK2 Inhibition Induces p53-Dependent Senescence in Glioblastoma Cells

  2020cites this paper
• Tristetraprolin regulates necroptosis during tonic Toll-like receptor 4 (TLR4) signaling in murine macrophages

  2020cites this paper
• Future Therapeutic Directions for Smac-Mimetics

  2020cites this paper
• RIPK1 Kinase-Dependent Death: A Symphony of Phosphorylation Events.

  2020cites this paper
• Death Receptors and Their Ligands in Inflammatory Disease and Cancer.

  2020cites this paper
• SNIPERs-Hijacking IAP activity to induce protein degradation.

  2019cites this paper
• The roles of ubiquitination in extrinsic cell death pathways and its implications for therapeutics.

  2019cites this paper
• Post-translational modification of the death receptor complex as a potential therapeutic target in cancer

  2019cites this paper
• SMAC mimetics as potential cancer therapeutics in myeloid malignancies

  2019cites this paper
• Exploiting Necroptosis for Therapy of Acute Lymphoblastic Leukemia

  2019cites this paper
• Inhibitor of Apoptosis Proteins Determines Glioblastoma Stem‐Like Cell Fate in an Oxygen‐Dependent Manner

  2019cites this paper
• cIAP1/2 inhibition synergizes with TNF inhibition in autoimmunity by down-regulating IL-17A and inducing Tregs

  2019cites this paper
• Precision medicine for TP53-mutated acute myeloid leukemia

  2019cites this paper
• Ptpn6 inhibits caspase-8- and Ripk3/Mlkl-dependent inflammation

  2019cites this paper
• Intracellular apoptotic pathways: a potential target for reducing joint damage in rheumatoid arthritis

  2018cites this paper
• Checkpoints in TNF-Induced Cell Death: Implications in Inflammation and Cancer.

  2018cites this paper
• Neuroprotective Effect of Sirt2-specific Inhibitor AK-7 Against Acute Cerebral Ischemia is P38 Activation-dependent in Mice.

  2018cites this paper
• A post-transcriptional program of chemoresistance by AU-rich elements/TTP in cancer quiescence

  2018cites this paper
• Recent advances in understanding inhibitor of apoptosis proteins

  2018cites this paper
• Necroinflammation emerges as a key regulator of hematopoiesis in health and disease

  2018cites this paper
• Recent advances in understanding inhibitor of apoptosis proteins [version 1; referees: 2 approved]

  2018cites this paper
• RIPK1 prevents TRADD-driven, but TNFR1 independent, apoptosis during development

  2018cites this paper
• The pseudokinase MLKL activates PAD4-dependent NET formation in necroptotic neutrophils

  2018cites this paper
• Therapeutic manipulation of host cell death pathways to facilitate clearance of persistent viral infections

  2018cites this paper
• Differentiated macrophages acquire a pro-inflammatory and cell death–resistant phenotype due to increasing XIAP and p38-mediated inhibition of RipK1

  2018cites this paper
• Expression of the IFNAR1 chain of type 1 interferon receptor in benign cells protects against progression of acute leukemia

  2018cites this paper
• Inhibition of MK2 suppresses IL‐1β, IL‐6, and TNF‐α‐dependent colorectal cancer growth

  2018cites this paper
• To die or not to die: Regulatory feedback phosphorylation circuits determine receptor-interacting protein kinase-1 (RIPK1) function

  2018cites this paper
• Phosphothreonine Lyase Promotes p65 Degradation in a Mitogen-Activated Protein Kinase/Mitogen- and Stress-Activated Protein Kinase 1-Dependent Manner

  2018cites this paper
• Inhibitor of apoptosis proteins determine glioblastoma stem-like cells fate depending on oxygen level

  2018cites this paper
• Platelet procoagulant phenotype is modulated by a p38-MK2 axis that regulates RTN4/Nogo proximal to the endoplasmic reticulum: utility of pathway analysis.

  2018cites this paper
• MK2-TNF-Signaling Comes Full Circle.

  2017cites this paper
• JNK1 negatively controls anti-fungal innate immunity by suppressing CD23 expression

  2017cites this paper
• p38MAPK/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection

  2017cites this paper
• Regulation of expression and trafficking of perforin-2 by LPS and TNF-α.

  2017cites this paper
• Killing AML: RIPK3 leads the way

  2017cites this paper
• Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells

  2017cites this paper
• MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death

  2017cites this paper
• Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients

  2017cites this paper
• Relevance of necroptosis in cancer

  2017cites this paper
• Therapeutic opportunities based on caspase modulation.

  2017cites this paper
• Bivalent IAP antagonists, but not monovalent IAP antagonists, inhibit TNF-mediated NF-κB signaling by degrading TRAF2-associated cIAP1 in cancer cells

  2017cites this paper
• Selective replication of oncolytic virus M1 results in a bystander killing effect that is potentiated by Smac mimetics

  2017cites this paper
• MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death

  2017cites this paper
• Targeting apoptosis in acute myeloid leukaemia

  2017cites this paper
• 'Did He Who Made the Lamb Make Thee?' New Developments in Treating the 'Fearful Symmetry' of Acute Myeloid Leukemia.

  2017cites this paper
• Smac Mimetics to Therapeutically Target IAP Proteins in Cancer.

  2017cites this paper
• Hyperosmotic stress enhances cytotoxicity of SMAC mimetics

  2017cites this paper
• The role of MAP2 kinases and p38 kinase in acute murine liver injury models

  2017cites this paper
• PD-L1 and IAPs co-operate to protect tumors from cytotoxic lymphocyte-derived TNF

  2017cites this paper
• Cell Death Signaling Complexes During Macrophage Differentiation

  2017cites this paper
• Activation of necroptosis to overcome drug resistance in leukemia

  2016cites this paper
• A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis.

  2016cites this paper
• Preclinical evaluation of apoptosis resensitisation with Inhibitor-of-apoptosis-protein (IAP) antagonist in glioblastoma cell lines and in an orthotopic mouse GBM model

  2016cites this paper
• TNFα-Mediated Cytotoxic Responses to IAP Inhibition Are Limited by the p38α MAPK Pathway.

  2016influential citation
• RIPK3-dependent cell death and inflammasome activation in FLT3-ITD expressing LICs

  2016cites this paper
• GATA Factor-Dependent Positive-Feedback Circuit in Acute Myeloid Leukemia Cells.

  2016cites this paper
• Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis

  2016cites this paper
• p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the Story

  2016cites this paper
• Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics.

  2016cites this paper
• Bivalent IAP antagonists inhibit TRAF2-bound cIAPs and limit TNF-mediated NF-κB signaling

  2016cites this paper